30142 Wixom Road
327 articles with Rockwell Medical
Rockwell Medical, Inc. today reported financial results for the third quarter ended September 30, 2018, and highlighted recent and upcoming corporate milestones.
Mr. Smith will be responsible for overseeing all financial operations and investor relations activities for the Company.
Rockwell Medical, Inc. today announced that it will hold a conference call to discuss third quarter 2018 financial results on Friday, November 9, 2018.
Initial closing of $22 million, with total proceeds of up to $30 million
Rockwell Medical (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today provided an update on the status of the Company's development of an intravenous ("IV") formulation of the Company's proprietary drug Triferic®, which is the only FDA-approved therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease.
Rockwell Medical, Inc. announced that Anne Boardman has been appointed Vice President, Strategic Accounts, effective today, October 1, 2018.
Rosen Law Firm Reminds Rockwell Medical, Inc. Investors of Important Deadline in Class Action Seeking Investor Losses - RMTI
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rockwell Medical, Inc. between March 16, 2018 and June 26, 2018, inclusive (the "Class Period") of the important September 25, 2018 lead plaintiff deadline in the class action.
Rockwell Medical, Inc. today announced that Jim McCarthy, has been appointed Senior Vice President, Corporate and Business Development, effective September 4, 2018.
RMTI LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Rockwell Medical, Inc. - RMTI
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rockwell Medical, Inc. (NASDAQ: RMTI) between March 16, 2018 and June 26, 2018
Rockwell Loss Alert: Bernstein Liebhard LLP Announces Investigation Of Rockwell Medical, Inc. - RMTI
Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Rockwell Medical, Inc.
Rockwell Medical, Inc. Provides Business Update, Reports Second Quarter 2018 Financial Results and Restates First Quarter 2018 Financial Results
Rockwell Medical, Inc. provided a business update, financial results for the second quarter ended June 30, 2018 and announced the restatement of its financial results for the first quarter ended March 31, 2018.
Stuart Paul Brings Significant Healthcare Experience
Rockwell Medical, Inc. announced that the Company and five members of the Rockwell Medical Board of Directors have entered into a settlement agreement with Robert Chioini, Thomas Klema, Patrick Bagley and Ronald Boyd.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Rockwell Medical, and Impinj and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. announces that class action lawsuits have been commenced on behalf of stockholders of Mercury Systems, Inc., Rockwell Medical, Inc., and Impinj, Inc.
RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Rockwell Medical, Inc. securities between March 16, 2018 and June 26, 2018, inclusive (the "Class Period").
Rockwell Medical Schedules Second Quarter 2018 Business Update Conference Call and Provides Timeline of Form 10-Q Filing
Rockwell Medical, Inc. announced that it will hold a conference call to provide commentary on the business on Tuesday, August 14, 2018, at 5:00 pm Eastern Time.
Securities Class Action Filed Against Rockwell Medical, Inc. (RMTI); Block & Leviton Encourages Rockwell Investors to Contact The Firm
Block & Leviton LLP announces that a securities fraud class action has been filed against Rockwell Medical, Inc. and certain of its officers alleging violations of the federal securities laws.
Rockwell Medical, Inc. announced that the Audit Committee of its Board of Directors has engaged Marcum LLP as Rockwell Medical's new independent registered public accounting firm.
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Rockwell Medical, Inc. (RMTI) and Lead Plaintiff Deadline - September 25, 2018
ronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rockwell Medical, Inc.
Whistleblower Complaint, Investigation Demands and Claimed Breaches of Fiduciary Duty Are Part of...
7/11/2018The lawsuit and counter-lawsuits over the ouster of Rockwell Medical’s chief executive officer can be convoluted to follow, particularly as allegations are thrown around. BioSpace has put together a synopsis of the events.